EPIGRAL / NSE / Chemical Manufacturing
Epigral
1Y Price Trend
Key Information
Recommendations
RatingStrong Buy
Target High2,114.3
Target Low806.2
Target Mean1
Target Median0
Risk Metrics
Overall RiskHigh risk
Board Risk45.17
Key Analysis
Overall score, performance score, return rating, defensive, aggressive, and balanced views.
Download appProjection Analytics
Best-case, base-case, worst-case, and dynamic AI projection views.
Download appLatest stock news
Epigral Ltd is Rated Sell Markets Mojo
Epigral Ltd is Rated Sell Markets Mojo
Epigral Limited Fixes June 1 Record Date for 19th AGM, e-Voting and ₹5 Dividend scanx.trade
Epigral Limited (NSE:EPIGRAL) Passed Our Checks, And It's About To Pay A ₹5.00 Dividend simplywall.st
Epigral Limited Annual Secretarial Compliance Report for FY 2025-26 Filed InvestyWise
Epigral Ltd is Rated Sell Markets Mojo
Epigral Ltd Valuation Shifts Signal Renewed Price Attractiveness Amid Specialty Chemicals Sector Markets Mojo
Epigral approves re-appointment of three directors scanx.trade
© SharekeyX | Rusaka Technologies 2024-2026